Flovent asthma
Pro Research Analysisby 
Searched over 200M research papers for "flovent asthma"
Flovent in Asthma Management: Efficacy, Safety, and Comparative Studies
Introduction to Flovent for Asthma Treatment
Flovent, a brand name for fluticasone propionate, is a corticosteroid used in the maintenance treatment of asthma. It is available in various forms, including dry powder inhalers (Diskus) and metered-dose inhalers (HFA). This article synthesizes research findings on the efficacy, safety, and comparative effectiveness of Flovent in asthma management.
Efficacy of Flovent in Asthma Control
Twice-Daily vs. Once-Daily Dosing
Research has shown that twice-daily dosing of Flovent Diskus is more effective than once-daily dosing. In six clinical trials, twice-daily dosing was superior in improving pre-dose FEV1, a primary measure of lung function. Once-daily dosing did not show significant benefits over placebo in most trials, except for one where a higher dose (500 microg) was used, but even then, the effect was only half as strong as the twice-daily regimen .
Pediatric Asthma Management
In children aged 4 to 11 with persistent asthma, both once-daily and twice-daily dosing of dry powder Flovent (200 microg per day) significantly improved FEV1, evening peak expiratory flow (PEF), and asthma symptoms. However, the twice-daily regimen also significantly improved morning PEF and reduced nighttime awakenings due to asthma. Flovent was well tolerated over a 64-week period with minimal adverse events .
Comparative Effectiveness of Flovent
Flovent vs. Beclomethasone
Studies comparing Flovent (fluticasone propionate) with beclomethasone dipropionate (BDP) have shown that Flovent is at least as effective as BDP in controlling asthma. Flovent demonstrated therapeutic effects earlier than BDP without significant adverse effects . Additionally, Flovent HFA showed lower lung deposition compared to QVAR (HFA-beclomethasone), which may be attributed to the larger particle size of Flovent HFA .
Flovent vs. Salmeterol/Fluticasone Combination
The GOAL study compared the combination of salmeterol and fluticasone (SFC) with fluticasone alone. Results indicated that more patients achieved total asthma control with the combination therapy than with fluticasone alone, regardless of previous treatment levels .
Safety and Bioavailability
Systemic Exposure and Bioavailability
A study comparing the systemic bioavailability of fluticasone delivered via different devices found that Flovent HFA had higher systemic exposure compared to Xhance (an exhalation delivery system) and Flonase (nasal spray). However, systemic exposure was still relatively low across all products . In young children, the use of antistatic valved holding chambers (VHCs) with Flovent HFA significantly increased lung bioavailability, suggesting that device choice can impact drug delivery efficiency .
Long-Term Safety in Children
Long-term use of Flovent in children has been shown to be safe, with few reports of drug-related adverse events or abnormalities in morning plasma cortisol levels, indicating minimal systemic side effects .
Conclusion
Flovent is a highly effective corticosteroid for the maintenance treatment of asthma, particularly when administered twice daily. It is well-tolerated in both adults and children, with minimal adverse effects. Comparative studies suggest that Flovent is as effective as other inhaled corticosteroids like beclomethasone and may offer earlier therapeutic benefits. The choice of delivery device can significantly impact the drug's bioavailability and efficacy, especially in pediatric patients. Overall, Flovent remains a cornerstone in asthma management, providing reliable control of symptoms and improving lung function.
Sources and full results
Most relevant research papers on this topic
Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
Once-daily dosing of fluticasone propionate for asthma treatment is not recommended due to lack of safety and adherence advantages compared to twice-daily dosing.
Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
Dry powder fluticasone propionate 200 microg once daily is an effective and convenient alternative for children with persistent asthma, improving pulmonary function and reducing asthma symptoms.
DOI